@article{ee4c2f9dae304d379165581d8cb563d2,
title = "Antitumor response of an ERBB2 amplified inflammatory breast carcinoma with EGFR mutation to the EGFR-TKI erlotinib",
keywords = "ErbB Receptors/antagonists \& inhibitors, Erlotinib Hydrochloride, Female, Humans, Inflammatory Breast Neoplasms/drug therapy, Middle Aged, Mutation, Protein Kinase Inhibitors/therapeutic use, Quinazolines/therapeutic use",
author = "Ali, \{Siraj M\} and Alpaugh, \{R Kathy\} and Buell, \{Jamie K\} and Stephens, \{Philip J\} and Yu, \{Jian Qin Michael\} and Hong Wu and Hiemstra, \{Christine N\} and Miller, \{Vincent A\} and Doron Lipson and Palmer, \{Gary A\} and Ross, \{Jeffrey S\} and Massimo Cristofanilli",
year = "2014",
month = feb,
doi = "10.1016/j.clbc.2013.09.010",
language = "English",
volume = "14",
pages = "e14--e16",
journal = "Clinical Breast Cancer",
issn = "1526-8209",
publisher = "Elsevier Inc.",
number = "1",
}